|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7004 | |
| A61K 31/351 | |||
| A61P 19/06 |
| (11) | Patento numeris | 2291189 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09751249.5 |
| Europos patento paraiškos padavimo data | 2009-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/044156 |
| Data | 2009-05-15 |
| (87) | Numeris | WO 2009/143020 |
| Data | 2009-11-26 |
| (30) | Numeris | Data | Šalis |
| 55352 P | 2008-05-22 | US |
| (72) |
LESLIE, Bruce, Robert, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME |
| METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME |